Development, option and STOCK PURCHASE AGREEMENT BY AND AMONG alexion Pharmaceuticals, INC., caelum biosciences, Inc., The Sellers, And fortress biotech, inc., as the representative DATED AS OF January 30, 2019Development, Option and Stock Purchase Agreement • May 10th, 2019 • Fortress Biotech, Inc. • Pharmaceutical preparations • Delaware
This development, option and STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 30, 2019, by and among Alexion Pharmaceuticals, Inc., a Delaware Corporation (the “Buyer”), Caelum Biosciences, Inc., a Delaware corporation (the “Company”), the holders of the securities of the Company listed on Exhibit A and signatories hereto (collectively, the “Sellers”), and Fortress Biotech, Inc. (“Fortress”), in its capacity as the Representative.
